Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. November 2024 07:00 ET | Quelle: Kanglin Biotec

Kanglin Biotechnology Announces $20 Million Series A Financing to Advance the Development of Gene Therapies

- Phase 1 study and Investigator Initiated Trial evaluating KL003 for patients with beta thalassemia demonstrated an encouraging efficacy signal and favorable safety profile – - Manufacturing costs...
30. Oktober 2023 04:30 ET | Quelle: Transparency Market Research

Gene Vectors Market Predicted to Rise at a 12.6% CAGR until 2031, Reaching US$ 3.4 billion: TMR Report

Wilmington, Delaware, United States, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - TMR predicted that the gene vector market is likely to reach US$ 3.4 billion by 2031. Gene...
19. Mai 2023 09:10 ET | Quelle: Persistence Market Research

Viral Vector Vaccines Market Size to Surpass US$ 1.23 billion by 2033 | Persistence Market Research

New York, May 19, 2023 (GLOBE NEWSWIRE) -- The global viral vector vaccines market was valued at US$ 738.4 million in 2022 and is projected to expand at a CAGR of 3.9% over the forecast period (2023...